BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17619556)

  • 1. Montelukast in allergic diseases beyond asthma.
    Leonardi S; Marchese G; Marseglia GL; La Rosa M
    Allergy Asthma Proc; 2007; 28(3):287-91. PubMed ID: 17619556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antileukotrienes in paediatrics.
    Aprile A; Lucarelli S; Vagnucci B; Frediani T
    Eur Rev Med Pharmacol Sci; 2001; 5(2):53-7. PubMed ID: 11863319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
    Broshtilova V; Gantcheva M
    Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?
    Kägi MK
    Dermatology; 2001; 203(4):280-3. PubMed ID: 11752812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast in general pediatric practices.
    Ngamphaiboon J
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
    Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I; Tsankov N
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of montelukast on basophil releasability in patients with asthma.
    Sade K; Kivity S; Fireman E; Schwartz Y; Kivity S
    Isr Med Assoc J; 2005 Dec; 7(12):792-5. PubMed ID: 16382702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
    Lehtimäki L; Petäys T; Haahtela T
    Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of montelukast in the treatment of asthma and allergic rhinitis.
    Nayak A
    Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene inhibitors in the treatment of allergy and asthma.
    Scow DT; Luttermoser GK; Dickerson KS
    Am Fam Physician; 2007 Jan; 75(1):65-70. PubMed ID: 17225706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field.
    Nettis E; D'Erasmo M; Di Leo E; Calogiuri G; Montinaro V; Ferrannini A; Vacca A
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20886028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
    Steinke JW; Culp JA
    Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell mediators cause early allergic bronchoconstriction in guinea-pigs in vivo: a model of relevance to asthma.
    Riley JP; Fuchs B; Sjöberg L; Nilsson GP; Karlsson L; Dahlén SE; Rao NL; Adner M
    Clin Sci (Lond); 2013 Dec; 125(11):533-42. PubMed ID: 23799245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukotriene antagonist. All around talent in asthma and allergies].
    MMW Fortschr Med; 2002 Nov; 144(47):64. PubMed ID: 12532531
    [No Abstract]   [Full Text] [Related]  

  • 17. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
    Nayak A; Langdon RB
    Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukotriene drugs: clinical application, effectiveness and safety.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio C; D'Orazio N
    Curr Med Chem; 2007; 14(18):1966-77. PubMed ID: 17691939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders.
    Jo-Watanabe A; Okuno T; Yokomizo T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis.
    Cobanoğlu B; Toskala E; Ural A; Cingi C
    Curr Allergy Asthma Rep; 2013 Apr; 13(2):203-8. PubMed ID: 23389557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.